Here are three updates from Xtant Medical so far in 2025.
1. Xtant Medical launched OsteoFactorPro, a naturally derived, growth factor-rich formulation for spine and orthopedics. OsteoFactorPro is designed to enhances the biologic activity and regenerative potential of any orthobiologic scaffold.
2. Xtant Medical is selling certain Coflex and CoFix spinal implants and all OUS entities of Paradigm Spine GmbH to Companion Spine. The assets sold for $19.2 million, and Xtant Medical plans to use the money to reduce long-term debt and add to cash liquidity.
3. Xtant Medical’s second-quarter sales reached $35.4 million, according to financial results posted Aug. 12. The company saw net income of $3.6 million compared to a net loss of $3.9 million in the same time in 2024.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
